These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 12949795)
1. ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma. Guan X; Sagara J; Yokoyama T; Koganehira Y; Oguchi M; Saida T; Taniguchi S Int J Cancer; 2003 Nov; 107(2):202-8. PubMed ID: 12949795 [TBL] [Abstract][Full Text] [Related]
2. Methylation of ASC/TMS1, a proapoptotic gene responsible for activating procaspase-1, in human colorectal cancer. Yokoyama T; Sagara J; Guan X; Masumoto J; Takeoka M; Komiyama Y; Miyata K; Higuchi K; Taniguchi S Cancer Lett; 2003 Dec; 202(1):101-8. PubMed ID: 14643031 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Stone AR; Bobo W; Brat DJ; Devi NS; Van Meir EG; Vertino PM Am J Pathol; 2004 Oct; 165(4):1151-61. PubMed ID: 15466382 [TBL] [Abstract][Full Text] [Related]
5. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908 [TBL] [Abstract][Full Text] [Related]
6. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776 [TBL] [Abstract][Full Text] [Related]
7. Silencing of metallothionein 1A gene in melanoma. Nobeyama Y; Nakagawa H J Dermatol Sci; 2017 Nov; 88(2):232-237. PubMed ID: 28764861 [TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions. Sharma BK; Smith CC; Laing JM; Rucker DA; Burnett JW; Aurelian L Dermatology; 2006; 213(3):192-9. PubMed ID: 17033167 [TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. Stimson KM; Vertino PM J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524 [TBL] [Abstract][Full Text] [Related]
10. Effects of methylation on expression of TMS1/ASC in human breast cancer cells. Levine JJ; Stimson-Crider KM; Vertino PM Oncogene; 2003 May; 22(22):3475-88. PubMed ID: 12776200 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic down-regulation of death-associated protein kinase in lung cancers. Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of TMS1/ASC in ovarian cancer. Terasawa K; Sagae S; Toyota M; Tsukada K; Ogi K; Satoh A; Mita H; Imai K; Tokino T; Kudo R Clin Cancer Res; 2004 Mar; 10(6):2000-6. PubMed ID: 15041718 [TBL] [Abstract][Full Text] [Related]
13. Dual role of TMS1/ASC in death receptor signaling. Parsons MJ; Vertino PM Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133 [TBL] [Abstract][Full Text] [Related]
14. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Gonzalgo ML; Bender CM; You EH; Glendening JM; Flores JF; Walker GJ; Hayward NK; Jones PA; Fountain JW Cancer Res; 1997 Dec; 57(23):5336-47. PubMed ID: 9393758 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells. Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472 [TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells. Wada K; Maesawa C; Akasaka T; Masuda T J Invest Dermatol; 2004 Mar; 122(3):805-11. PubMed ID: 15086568 [TBL] [Abstract][Full Text] [Related]
18. PAX4 has the potential to function as a tumor suppressor in human melanoma. Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370 [TBL] [Abstract][Full Text] [Related]
19. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676 [TBL] [Abstract][Full Text] [Related]
20. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL. Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]